by Underlying Psychiatric Disorders
Newswise — New York, NY (November 29, 2021) In the largest genetic study of suicide attempts to date, researchers have identified a region of the genome on chromosome 7 containing DNA variations that increase the risk that a person will attempt suicide.
The study also found overlap in the genetic basis of suicide attempts and that of related psychiatric disorders, particularly major depression, and also with that of non-psychiatric risk factors such as smoking, risk-taking behavior, sleep disturbances, and poorer general health. The study results, published November 30 in Biological Psychiatry, suggest that the genetic underpinnings of suicide attempts are partially shared and partially distinct from those of related psychiatric disorders.
Suicide is a worldwide public health problem, accounting for almost 800,000 deaths per year. Non-fatal suicide attempts are estimated to occur more than 20 times for every death by suicide and are a major source of disability, reduced quality of life, and social and economic burden. Suicidal thoughts and behaviors can be reduced with proper mental health support and treatment. Therefore, it is critical to gain insight into the underlying biological pathways involved in suicide attempts or suicidal thoughts, which could provide potential avenues to treatment and prevention strategies.
To help elucidate the underlying biology of suicide attempts, an international consortium of scientists from the International Suicide Genetics Consortium conducted a genome-wide association study. This method involves scanning the DNA of many people, looking for genetic markers that were more common in those who had made a suicide attempt. The team scanned more than 7.5 million common variations in the DNA sequence of nearly 550,000 people, almost 30,000 of whom had made a suicide attempt.
“In addition to identifying the risk location for suicide attempt on chromosome 7, we uncovered a strong overlap in the genetic basis of suicide attempt and that of psychiatric disorders, particularly major depression, as well as some overlap with the genetics of smoking, pain, risk-taking, sleep disturbances, and poorer general health,” said Niamh Mullins, PhD, Assistant Professor of Psychiatric Genomics at the Icahn School of Medicine at Mount Sinai, co-founder and co-chair of the consortium, and lead author of the paper. “This genetic overlap with non-psychiatric risk factors was largely unchanged by adjusting for psychiatric disorders, which suggests that a substantial component of the biological basis of suicide attempt is not simply a byproduct of comorbid psychiatric disease, but instead may be the result of shared biology with non-psychiatric risk factors.”
The association between genetic variations on chromosome 7 and risk of attempting suicide was also not mediated by comorbid psychiatric disorders, and was replicated through an independent analysis of more than 14,000 veterans who had made a suicide attempt from the Million Veterans Program, a national research program to learn how genes, lifestyle, and military exposures affect health and illness.
“This study is an exciting advancement of our understanding of how the genetics of suicide attempt relate to that of psychiatric and non-psychiatric risk factors,” said JooEun Kang, an MD-PhD student at Vanderbilt University Medical Center and co-lead author of this paper.
DNA variations in this region have previously been linked with insomnia, smoking, and risk-taking behavior, and although future work is needed to uncover the underlying biological mechanism, findings like these bring researchers a step closer to understanding the neurobiology of suicidality.
“The study findings also point to the importance of studying the potential direct causal paths between these risk factors and suicide attempt in patients with and without psychiatric illness,” added Douglas Ruderfer, PhD Associate Professor of Genetic Medicine, Psychiatry, and Biomedical Informatics at Vanderbilt University Medical Center, co-founder and co-chair of the consortium, and senior author of the paper.
The International Suicide Genetics Consortium includes more than 260 scientists in more than 20 countries who are dedicated to studying the genetic basis of suicidality. Their work provides the foundation for future larger studies to identify genetic risk factors for suicide attempts in other areas of the genome, as well as additional studies focused on suicidal thoughts. The ultimate goal of this research is to gain insight into the underlying biological pathways involved in suicidality, providing potential avenues to treatments and prevention strategies.
If you are in crisis, please call the National Suicide Prevention 24-hour Lifeline at 1-800-273-TALK (8255), or contact the Crisis Text Line by texting TALK to 741741, or visit their website at: http://suicidepreventionlifeline.org.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. We advance medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,300 primary and specialty care physicians; 13 free-standing joint-venture centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island; and more than 30 affiliated community health centers. The Mount Sinai Hospital is ranked in U.S. News & World Report's "Honor Roll" of the top 20 U.S. hospitals and among the top in the nation by specialty: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Urology, and Rehabilitation. Mount Sinai Kravis Children's Hospital is ranked in U.S. News & World Report’s “Best Children’s Hospitals” among the country’s best in four out of 10 pediatric specialties. New York Eye and Ear Infirmary of Mount Sinai is ranked among the Top 20 nationally for ophthalmology. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and No. 14 in the nation for National Institutes of Health funding. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and top five globally, and Mount Sinai Morningside as top 20 globally, and “The World’s Best Specialized Hospitals” ranks Mount Sinai Heart as No. 1 in New York and No. 4 globally and the Division of Gastroenterology as No. 3 globally. For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.